|
|
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target- |
MechanismCell death stimulants [+1] |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target- |
MechanismCell death stimulants |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with HKND YB1 PHARMACEUTICAL (Shenzhen) Co., Ltd.
0 Patents (Medical) associated with HKND YB1 PHARMACEUTICAL (Shenzhen) Co., Ltd.
100 Deals associated with HKND YB1 PHARMACEUTICAL (Shenzhen) Co., Ltd.
100 Translational Medicine associated with HKND YB1 PHARMACEUTICAL (Shenzhen) Co., Ltd.